Beckman Research Institute Of The City Of Hope

Name

Beckman Research Institute Of The City Of Hope

Legal name

Beckman Research Institute of City of Hope

Website

https://cityofhope.org

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

5,001–10,000 employees

Ownership category

akta.pro rank

Product category

Cancer Treatment and Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

akta.pro secondary industries

Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC), Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM), Health & Medical Research Grantmaking Foundations (BPAGAKAL)

Keywords

• Cancer research
• Clinical trials
• Translational genomics
• Cell therapy development
• Biomedical research

Headquarters

HQ city

Duarte

HQ country

United States

HQ region

North America

Offices7 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Patient Care Services: Revenue from providing cancer treatment, hospital services, and medical care to patients. City of Hope National Medical Center provides hospital/technical services while City of Hope Medical Foundation provides physician services.
2. Philanthropy and Donations: Major revenue stream from individual donors, corporate philanthropy, planned giving, walk events (Walk for Hope), and foundation relations. Multiple fundraising programs including monthly giving, memorial gifts, and major donor cultivation.
3. Clinical Research and Grants: Funding from conducting clinical trials and research programs. City of Hope conducts more than 400 clinical trials annually enrolling more than 6,000 patients, with research supported by grants from organizations including JDRF.
4. Health Insurance Reimbursement: Revenue from contracted health plans including Medicare, MediCal, Tricare/Champus, PPO, HMO, and Covered California. City of Hope contracts with most major health plans for hospital and physician services.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels8 records

Core offering

Beckman Research Institute of the City of Hope is a research institute that conducts basic and translational biomedical research across cancer, diabetes, HIV/AIDS, and other life-threatening diseases. It operates as part of City of Hope's integrated platform of five research institutes, a national network of NCI-designated cancer treatment centers, and a graduate school of biological sciences, delivering therapies from laboratory to patient.

Product overview

City of Hope is a comprehensive cancer research and treatment organization built around a platform of five integrated research institutes: Beckman Research Institute, Arthur Riggs Diabetes & Metabolism Research Institute, Comprehensive Cancer Center, Hematologic Malignancies Research Institute, and Translational Genomics Research Institute (TGen). These institutes operate alongside a national network of cancer treatment centers providing patient care, and are supported by the Irell & Manella Graduate School of Biological Sciences for academic training. The organization offers clinical trials (400+ annually), cancer treatment services, diabetes research and care, and graduate education programs as interconnected components of its biomedical research mission.

Differentiator

Problem solved

Functional benefit

Brands

• Department of Cancer Biology and Molecular Medicine: Cancer biology and molecular medicine research department
• Department of Cancer Genetics and Epigenetics
• Department of Comparative Medicine
• Department of Computational and Quantitative Medicine
• Department of Hematologic Malignancies Translational Science
• Department of Immuno-Oncology
• Department of Integrative Translational Sciences
• Department of Molecular Diagnostics and Experimental Therapeutics
• Department of Neurodegenerative Diseases
• Department of Population Sciences
• Department of Stem Cell Biology & Regenerative Medicine
• Department of Systems Biology
• Center for Cancer and Aging
• Center for Precision Medicine
• Center for RNA Biology and Therapeutics

Products and services

• Beckman Research Institute A research institute pursuing breakthroughs in cancer, HIV/AIDS, and diabetes through departments in cancer biology, genetics, computational medicine, immuno-oncology, stem cell research, and other fields.
• Arthur Riggs Diabetes & Metabolism Research Institute A research institute dedicated to investigating the biology of diabetes and its treatment, including type 1 and type 2 diabetes, diabetes complications, and connections between diabetes and cancer.
• Comprehensive Cancer Center An NCI-designated comprehensive cancer center conducting research across five programs: Cancer Control and Population Sciences, Cancer Immunotherapeutics, Developmental Cancer Therapeutics, Hematologic Malignancies, and Molecular and Cellular Biology of Cancer.
• Hematologic Malignancies Research Institute A research and treatment institute for hematologic cancers including leukemia, lymphoma, myeloma, and related blood disorders, featuring centers for cellular immunotherapy, gene therapy, stem cell transplantation, and survivorship.
• Translational Genomics Research Institute (TGen) A genomics research institute affiliated with City of Hope that applies genomic analysis and bioinformatics to accelerate the translation of research discoveries into clinical applications for cancer and other diseases.
• Clinical Trials Program City of Hope conducts more than 400 clinical trials annually, enrolling approximately 6,000 patients, across its national network of cancer centers in California, Arizona, Georgia, and Illinois.
• Cancer Treatment Services Comprehensive cancer care including surgery, chemotherapy, radiation therapy, immunotherapy, cellular therapy (CAR T), and supportive care across multiple cancer types including solid tumors and hematologic malignancies.
• Irell & Manella Graduate School of Biological Sciences Graduate school offering M.S. degree in translational medicine and Ph.D. degree in biological sciences, housed within Beckman Research Institute.

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature5 records

Partnerships

Five partnerships are on record, tiered key and core.

• Omios BiologicskeyStrategic or Co-development Partner · 17 March 2026Material Transfer Agreement for evaluating Omios' proprietary biomarker-guided, non-attenuated oncolytic virus immunotherapy platform in solid tumor models. Research led by Dr. Stephen J. Forman at City of Hope focuses on breast, lung, GI, and pancreatic cancers. Collaboration represents a key step toward first-in-patient clinical trials for Omios' precision therapy platform.
• Omios BiologicskeyStrategic or Co-development Partner · 12 March 2026Material Transfer Agreement for advanced studies on proprietary biomarker-guided oncolytic virus platform in solid tumor models. City of Hope provides expertise in translational research and vaccinia oncolytic virus manufacturing. Research aims to validate platform as company progresses toward clinical trials.
• Translational Genomics Research Institute (TGen)coreStrategic or Co-development PartnerAlliance provides City of Hope access to TGen's innovative genomics technologies and bioinformatics capabilities for cancer drug development. TGen contributes genomic analysis expertise while City of Hope provides state-of-the-art clinical setting for advancing discoveries. Together transforming diagnosis, treatment and prevention of cancer through precision medicine.
• CIRM Alpha Stem Cell Clinic NetworkcoreStrategic or Co-development PartnerCity of Hope Alpha Stem Cell Clinic is part of the CIRM (California Institute for Regenerative Medicine) Alpha Stem Cell Clinic Network, accelerating stem cell-based clinical therapies and transitioning new disease treatments into sustainable patient-care programs.
• Calidi BiotherapeuticskeyStrategic or Co-development PartnerPhase 1 clinical trial collaboration for CLD-101 virotherapy in patients with recurrent high-grade glioma. City of Hope provides clinical trial infrastructure and research expertise for this innovative cancer therapy.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Memorial Sloan Kettering Cancer Center: U.S. News top-ranked NCI-designated cancer center with comparable integration of basic research, translational science, and high-volume clinical care; directly comparable peer for City of Hope's institute model.
• Dana-Farber Cancer Institute: Harvard-affiliated NCI-designated Comprehensive Cancer Center with a similarly strong research/clinical-trial footprint, including cellular immunotherapy and precision oncology — a direct peer on the translational oncology axis.
• Fred Hutchinson Cancer Center: Seattle-based NCI-designated cancer center with deep expertise in bone-marrow transplantation, immunotherapy, and clinical-trial operations — a directly comparable peer given City of Hope's hematologic malignancies and CAR-T focus.
• Mayo Clinic Comprehensive Cancer Center: Multi-site NCI-designated Comprehensive Cancer Center with model-integrated research/clinical practice and national referral base — comparable peer for City of Hope's national cancer-center expansion strategy.
• UCSF Helen Diller Family Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center with leading programs in precision oncology, immunotherapy, and clinical trials — a directly relevant peer for City of Hope's translational and genomic-medicine efforts.
• Stanford Cancer Institute: NCI-designated academic cancer center emphasizing cell therapy, genomics, and Phase 1 trial capacity — a directly comparable peer for City of Hope's CAR-T and translational genomics programs.
• MD Anderson Cancer Center: NCI-designated Comprehensive Cancer Center and the benchmark U.S. academic oncology hospital, operating a similar research-and-treatment platform with a graduate school, clinical trials program, and CAR-T/cell-therapy leadership — directly comparable to Beckman/City of Hope.
• Johns Hopkins Sidney Kimmel Comprehensive Cancer Center: NCI-designated academic cancer center with research-to-clinic translational infrastructure and a graduate/medical education program — closely comparable to City of Hope's Beckman/graduate-school model.

Broad incumbents

• Cedars-Sinai Medical Center (Samuel Oschin Cancer Center): Large Los Angeles-based academic health system with overlapping clinical care, research, and clinical-trial capacity; competes with City of Hope for SoCal oncology referrals but is a broader incumbent rather than a cancer-only specialist.

Regional players

• Emory Winship Cancer Institute: NCI-designated Comprehensive Cancer Center in Atlanta, directly comparable peer for City of Hope's Atlanta-area center given overlapping referral networks and similar research-care integration model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights8 records

Customer concentration

• LinkedInlinkedin.com/company/city-of-hope

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Beckman Research Institute Of The City Of Hope